| Original language | English (US) |
|---|---|
| Pages (from-to) | 1642-1644 |
| Number of pages | 3 |
| Journal | Journal of the American College of Cardiology |
| Volume | 74 |
| Issue number | 12 |
| DOIs | |
| State | Published - Sep 24 2019 |
| Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of the American College of Cardiology, Vol. 74, No. 12, 24.09.2019, p. 1642-1644.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Asymptomatic Patients With Abnormal Fractional Flow Reserve Treated With Medication Alone or With PCI
AU - Fournier, Stephane
AU - Kobayashi, Yuhei
AU - Fearon, William F.
AU - Collet, Carlos
AU - Roza da Costa, Bruno
AU - Rioufol, Gilles
AU - Pijls, Nico H.J.
AU - Jüni, Peter
AU - De Bruyne, Bernard
N1 - Funding Information: Please note: The Cardiovascular Center Aalst receives grant support from Abbott, Boston Scientific, Biotronik AG, and St Jude Medical. Dr. Fearon has received research support for Abbott and Medtronic; and has stock options with HeartFlow. Dr. Pijls has been a consultant for Abbott and Opsens; and holds equity in Philips, HeartFlow, and ASML. Dr. Jüni has received institutional research grants from AstraZeneca, Biotronik, Biosensors International, Eli Lilly, and The Medicines Company; and serves as an unpaid member of the steering group of trials funded by AstraZeneca, Biotronik, Biosensors, St. Jude Medical, and The Medicines Company. Dr. De Bruyne receives consulting fees through his institution from St. Jude Medical, Opsens, and Boston Scientific; and is a shareholder in Siemens, GE, Bayer, Philips, HeartFlow, Edwards Lifesciences, and Ceyliad. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. (Fractional Flow Reserve [FFR] Guided Percutaneous Coronary Intervention [PCI] Plus Optimal Medical Treatment [OMT] Versus OMT [FAME 2];NCT01132495).
PY - 2019/9/24
Y1 - 2019/9/24
UR - http://www.scopus.com/inward/record.url?scp=85072023946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85072023946&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2019.07.068
DO - 10.1016/j.jacc.2019.07.068
M3 - Letter
C2 - 31537275
AN - SCOPUS:85072023946
SN - 0735-1097
VL - 74
SP - 1642
EP - 1644
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 12
ER -